ASX Share rice
Sun 16 May 2021 - 01:22:am (Sydney)

RAP Share Price

RESAPP HEALTH LIMITEDRAPHealth Care Equipment & Services

RAP Company Information

Name:

ResApp Health Limited

Sector:

Healthcare

Industry:

Health Information Services

GIC Industry:

Health Care Technology

GIC Sub Industry:

Health Care Technology

Address:

100 Creek Street Brisbane QLD Australia 4000

Phone:

61 7 3724 0035

Full Time Employees:

500

CEO, MD & Director:

Dr. Anthony Keating

VP of Fin.:

Al Rey Lunar CPA

Company Sec.:

Ms. Nicki Farley

Founder and Director of R&D of Cavidi AB:

Dr. Clas Källander

VP of Corp. Affairs:

Mr. Brian Leedman BECON, M.B.A., B.Econ.

Scientific Advisor:

Dr. Paul Porter

Company Overview:

ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company offers ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department, and primary care markets; and SleepCheck, a direct-to-consumer smartphone application for the self-assessment of sleep apnoea in 36 countries. Its technology uses sound to diagnose respiratory diseases, including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease, and asthma. ResApp Health Limited has a joint development and pilot agreement with Medgate AG to integrate and test smartphone-based acute respiratory diagnostic test. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was founded in 2014 and is headquartered in Brisbane, Australia.

RAP Share Price Information

Shares Issued:

859.20M

Market Capitalisation:

$40.38M

Revenue (TTM):

$46.20K

Earnings per Share:

$-0.008

Operating Margin (TTM):

$-169.14

Return On Assets (TTM):

$-0.69

Return On Equity (TTM):

$-1.51

Quarterly Revenue Growth (YOY):

-0.323

Gross Profit(TTM):

$1.02M

Diluted Earnings Per Share (TTM):

$-0.011

RAP CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-113,423

Change To Liabilities:

$-307,438

Total Cashflow From Investing Activities:

$-113,423

Net Borrowings:

$-96,424

Net Income:

$-8,469,158

Total Cash From Operating Activities:

$-4,195,272

Depreciation:

$247.42K

Other Cashflow From Investing Activities:

$-103,673

Change To Account Receivables:

$1.10M

Sale Purchase Of Stock:

$5M

Capital Expenditures:

$9.75K

RAP Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-8,469,160

Net Income:

$-8,469,160

Operating Income:

$-8,469,150

Other Operating Expenses:

$-973,415

Total Revenue:

$51.23K

RAP Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$1.75M

Total Liabilities:

$1.86M

Total Stockholder Equity:

$7M

Other Current Liabilities:

$202.83K

Total Assets:

$8.85M

Common Stock:

$35.94M

Retained Earnings:

$-30,715,758

Other Liabilities:

$80.97K

Other Assets:

$103.67K

Cash:

$5.78M

Total Current Liabilities:

$1.58M

Property - Plant & Equipment:

$340.79K

Net Tangible Assets:

$5.25M

Long-Term Investments:

$103.67K

Total Current Assets:

$6.66M

Net Receivables:

$809.23K

Short-Term Investments:

$2.20M

Accounts Payable:

$358.30K

Short-Term Investments:

$2.20

Non Current Liabilities Total:

$271.97K

RAP Share Price History

RAP News

19 Apr, 2021
ResApp Health Limited ( ASX:RAP ) is possibly approaching a major achievement in its business, so we would like to...
17 Jan, 2021
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
22 Jul, 2020
ResApp Health Limited's (ASX:RAP): ResApp Health Limited develops digital healthcare solutions to assist doctors and...